CYP4Z1 and papillary adenocarcinoma: However, papillary adenocarcinoma tumors of either serous or mucinous subtypes showed discriminable expression of CYP4Z1 from other histopathological subtypes (91.7%, 44 cases and 100%, 14 cases, respectively).